vs
Apellis Pharmaceuticals, Inc.（APLS）与CECO ENVIRONMENTAL CORP（CECO）财务数据对比。点击上方公司名可切换其他公司
CECO ENVIRONMENTAL CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.0倍（$205.9M vs $199.9M），CECO ENVIRONMENTAL CORP同比增速更快（16.5% vs -5.9%），过去两年CECO ENVIRONMENTAL CORP的营收复合增速更高（22.4% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
CECO环保是1966年成立的美国工业技术企业，总部位于得克萨斯州达拉斯，在纳斯达克上市，股票代码为CECO。公司面向制造、化工、能源、炼油等工业领域，提供空气污染治理相关的技术、产品及服务，助力工业客户满足环保排放要求。
APLS vs CECO — 直观对比
营收规模更大
CECO
是对方的1.0倍
$199.9M
营收增速更快
CECO
高出22.5%
-5.9%
两年增速更快
CECO
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $205.9M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | 31.0% |
| 营业利润率 | -25.6% | 0.9% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | 16.5% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | $0.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSCECO
| Q1 26 | — | $205.9M | ||
| Q4 25 | $199.9M | $214.7M | ||
| Q3 25 | $458.6M | $197.6M | ||
| Q2 25 | $178.5M | $185.4M | ||
| Q1 25 | $166.8M | $176.7M | ||
| Q4 24 | $212.5M | $158.6M | ||
| Q3 24 | $196.8M | $135.5M | ||
| Q2 24 | $199.7M | $137.5M |
净利润APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | $-59.0M | $3.1M | ||
| Q3 25 | $215.7M | $1.5M | ||
| Q2 25 | $-42.2M | $9.5M | ||
| Q1 25 | $-92.2M | $36.0M | ||
| Q4 24 | $-36.4M | $4.9M | ||
| Q3 24 | $-57.4M | $2.1M | ||
| Q2 24 | $-37.7M | $4.5M |
毛利率APLSCECO
| Q1 26 | — | 31.0% | ||
| Q4 25 | — | 35.1% | ||
| Q3 25 | — | 32.7% | ||
| Q2 25 | — | 36.2% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 35.8% | ||
| Q3 24 | — | 33.4% | ||
| Q2 24 | — | 35.7% |
营业利润率APLSCECO
| Q1 26 | — | 0.9% | ||
| Q4 25 | -25.6% | 7.7% | ||
| Q3 25 | 48.7% | 4.8% | ||
| Q2 25 | -18.6% | 9.7% | ||
| Q1 25 | -50.0% | 35.0% | ||
| Q4 24 | -12.3% | 7.1% | ||
| Q3 24 | -24.0% | 5.3% | ||
| Q2 24 | -14.7% | 6.7% |
净利率APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | -29.5% | 1.4% | ||
| Q3 25 | 47.0% | 0.8% | ||
| Q2 25 | -23.6% | 5.1% | ||
| Q1 25 | -55.3% | 20.4% | ||
| Q4 24 | -17.1% | 3.1% | ||
| Q3 24 | -29.2% | 1.5% | ||
| Q2 24 | -18.9% | 3.3% |
每股收益（稀释后）APLSCECO
| Q1 26 | — | $0.98 | ||
| Q4 25 | $-0.40 | $0.09 | ||
| Q3 25 | $1.67 | $0.04 | ||
| Q2 25 | $-0.33 | $0.26 | ||
| Q1 25 | $-0.74 | $0.98 | ||
| Q4 24 | $-0.30 | $0.14 | ||
| Q3 24 | $-0.46 | $0.06 | ||
| Q2 24 | $-0.30 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $45.4M |
| 总债务越低越好 | — | $5.3M |
| 股东权益账面价值 | $370.1M | $317.2M |
| 总资产 | $1.1B | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资APLSCECO
| Q1 26 | — | $45.4M | ||
| Q4 25 | $466.2M | $33.1M | ||
| Q3 25 | $479.2M | $32.8M | ||
| Q2 25 | $370.0M | $36.8M | ||
| Q1 25 | $358.4M | $146.5M | ||
| Q4 24 | $411.3M | $37.8M | ||
| Q3 24 | $396.9M | $38.7M | ||
| Q2 24 | $360.1M | $36.5M |
总债务APLSCECO
| Q1 26 | — | $5.3M | ||
| Q4 25 | — | $212.4M | ||
| Q3 25 | — | $220.9M | ||
| Q2 25 | — | $238.7M | ||
| Q1 25 | — | $339.7M | ||
| Q4 24 | — | $218.9M | ||
| Q3 24 | — | $133.4M | ||
| Q2 24 | — | $130.8M |
股东权益APLSCECO
| Q1 26 | — | $317.2M | ||
| Q4 25 | $370.1M | $317.5M | ||
| Q3 25 | $401.2M | $309.2M | ||
| Q2 25 | $156.3M | $298.4M | ||
| Q1 25 | $164.2M | $285.8M | ||
| Q4 24 | $228.5M | $247.7M | ||
| Q3 24 | $237.1M | $241.3M | ||
| Q2 24 | $264.3M | $235.0M |
总资产APLSCECO
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.1B | $893.8M | ||
| Q3 25 | $1.1B | $891.9M | ||
| Q2 25 | $821.4M | $876.6M | ||
| Q1 25 | $807.3M | $957.1M | ||
| Q4 24 | $885.1M | $759.7M | ||
| Q3 24 | $901.9M | $621.5M | ||
| Q2 24 | $904.5M | $598.1M |
负债/权益比APLSCECO
| Q1 26 | — | 0.02× | ||
| Q4 25 | — | 0.67× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.55× | ||
| Q2 24 | — | 0.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | $-14.2M | $10.0M | ||
| Q3 25 | $108.5M | $15.3M | ||
| Q2 25 | $4.4M | $-7.7M | ||
| Q1 25 | $-53.4M | $-11.7M | ||
| Q4 24 | $19.4M | $1.8M | ||
| Q3 24 | $34.1M | $15.1M | ||
| Q2 24 | $-8.3M | $6.7M |
自由现金流APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | $7.3M | ||
| Q3 25 | $108.3M | $11.0M | ||
| Q2 25 | $4.4M | $-8.7M | ||
| Q1 25 | $-53.4M | $-15.1M | ||
| Q4 24 | $19.3M | $-4.3M | ||
| Q3 24 | — | $11.1M | ||
| Q2 24 | $-8.4M | $2.5M |
自由现金流率APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 3.4% | ||
| Q3 25 | 23.6% | 5.6% | ||
| Q2 25 | 2.5% | -4.7% | ||
| Q1 25 | -32.0% | -8.5% | ||
| Q4 24 | 9.1% | -2.7% | ||
| Q3 24 | — | 8.2% | ||
| Q2 24 | -4.2% | 1.9% |
资本支出强度APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 1.2% | ||
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 3.9% | ||
| Q3 24 | 0.0% | 3.0% | ||
| Q2 24 | 0.0% | 3.0% |
现金转化率APLSCECO
| Q1 26 | — | — | ||
| Q4 25 | — | 3.26× | ||
| Q3 25 | 0.50× | 10.18× | ||
| Q2 25 | — | -0.81× | ||
| Q1 25 | — | -0.33× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 7.24× | ||
| Q2 24 | — | 1.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
CECO
暂无分部数据
